home / stock / nbix / nbix short
Short Information | Neurocrine Biosciences Inc. (NASDAQ:NBIX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,205,400 |
Total Actual Volume | 15,770,154 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 110,270 |
Average Short Percentage | 13.78% |
Is there a NBIX Short Squeeze or Breakout about to happen?
See the NBIX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
04-25-2024 | $139.37 | $137.76 | $139.37 | $136.06 | 706,045 | 85,566 | 12.12% |
04-24-2024 | $140.89 | $138.97 | $144.7 | $138.01 | 883,288 | 94,168 | 10.66% |
04-23-2024 | $141 | $140.09 | $145 | $139.22 | 1,607,701 | 226,173 | 14.07% |
04-22-2024 | $132.48 | $133.66 | $134.1798 | $131.7949 | 575,067 | 121,311 | 21.1% |
04-19-2024 | $132.65 | $132 | $133.65 | $130.13 | 556,303 | 78,974 | 14.2% |
04-18-2024 | $133.23 | $132.54 | $134.2 | $131 | 586,541 | 73,406 | 12.52% |
04-17-2024 | $133.11 | $133.23 | $134.44 | $131.36 | 571,093 | 78,552 | 13.75% |
04-16-2024 | $131.78 | $132.99 | $135.18 | $131.49 | 1,033,219 | 107,717 | 10.43% |
04-15-2024 | $134.97 | $131.74 | $137 | $131.52 | 767,245 | 64,151 | 8.36% |
04-12-2024 | $136.22 | $134.66 | $137.78 | $134.63 | 577,344 | 93,688 | 16.23% |
04-11-2024 | $138.03 | $135.93 | $138.67 | $135.28 | 809,142 | 84,521 | 10.45% |
04-10-2024 | $138.45 | $138.09 | $140.535 | $137.09 | 639,131 | 86,430 | 13.52% |
04-09-2024 | $140.07 | $138.94 | $141.45 | $138 | 598,996 | 94,601 | 15.79% |
04-08-2024 | $138.03 | $139.44 | $139.68 | $137.72 | 615,701 | 81,320 | 13.21% |
04-05-2024 | $137.43 | $138.92 | $139.75 | $136.0301 | 458,610 | 58,910 | 12.85% |
04-04-2024 | $138.17 | $137.61 | $140.43 | $136.74 | 1,015,263 | 80,667 | 7.95% |
04-03-2024 | $137.72 | $137.59 | $140.185 | $137.36 | 614,144 | 77,437 | 12.61% |
04-02-2024 | $140.61 | $137.74 | $140.61 | $136.115 | 913,872 | 111,304 | 12.18% |
04-01-2024 | $137.3 | $141.38 | $141.75 | $136.845 | 995,785 | 141,514 | 14.21% |
03-28-2024 | $137.83 | $137.92 | $138.72 | $135.97 | 1,245,664 | 364,990 | 29.3% |
News, Short Squeeze, Breakout and More Instantly...
Neurocrine Biosciences Inc. Company Name:
NBIX Stock Symbol:
NASDAQ Market:
Neurocrine Biosciences Inc. Website:
2024-04-24 15:15:12 ET Wells Fargo analyst issues OVERWEIGHT recommendation for NBIX on April 23, 2024 04:12PM ET. The previous analyst recommendation was Buy. NBIX was trading at $139.345 at issue of the analyst recommendation. The overall analyst consensus : BUY. C...
Neurocrine Biosciences Launches WHAT THE C@H?! Educational Initiative to Support Congenital Adrenal Hyperplasia Community PR Newswire WHAT THE C@H?! provides a platform for the congenital adrenal hyperplasia (CAH) community to find educational information, share...
Neurocrine Biosciences Inc (NASDAQ:NBIX) revealed on Tuesday topline data for its Phase 2 SAVITRI study of NBI-1065845 in adult subjects with maj...